Cargando…
EGFR expression levels affect the mode of action of EGFR-targeting monoclonal antibodies
Epidermal growth factor receptor (EGFR) expression levels appear to modulate the efficacy of EGFR-targeting monoclonal antibodies. More specifically, we observed that high EGFR densities negatively affect the effects of EGFR-specific antibodies on EGFR phosphorylation yet exacerbate Fc-mediated tumo...
Autores principales: | Derer, Stefanie, Lohse, Stefan, Valerius, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667899/ https://www.ncbi.nlm.nih.gov/pubmed/23762793 http://dx.doi.org/10.4161/onci.24052 |
Ejemplares similares
-
Linking oncogenesis and immune system evasion in acquired resistance to EGFR-targeting antibodies: Lessons from a preclinical model
por: Garrido, Greta, et al.
Publicado: (2013) -
Convergence of EGFR glioblastoma mutations: evolution and allostery rationalizing targeted therapy
por: Orellana, Laura
Publicado: (2019) -
A mechanism for the response of KRAS(G13D) expressing colorectal cancers to EGFR inhibitors
por: McFall, Thomas, et al.
Publicado: (2020) -
Monoclonal antibody targeting of mononuclear cell chemokines driving malignant pleural effusion
por: Marazioti, Antonia, et al.
Publicado: (2014) -
A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma
por: Chandramohan, Vidyalakshmi, et al.
Publicado: (2013)